ResearcherJiaxing UniversityActive in the last 2 years

Xuanzeng Pei

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2534-4518; OpenAlex author ID A5036341846. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 2

FAM53B promotes pancreatic ductal adenocarcinoma metastasis by regulating macrophage M2 polarization. Co-author DOI 10.4251/wjgo.v16.i4.1479 ↗
LINC00261 elevation inhibits angiogenesis and cell cycle progression of pancreatic cancer cells by upregulating SCP2 via targeting FOXP3. First author DOI 10.1111/jcmm.16930 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dawei Jiang · 1 shared paper, 2024 · strength 0.24
- Paper FAM53B promotes pancreatic ductal adenocarcinoma metastasis by regulating macrophage M2 polarization. DOI 10.4251/wjgo.v16.i4.1479 ↗
Yifan Lu · 1 shared paper, 2024 · strength 0.24
- Paper FAM53B promotes pancreatic ductal adenocarcinoma metastasis by regulating macrophage M2 polarization. DOI 10.4251/wjgo.v16.i4.1479 ↗
Shuai Chen · 1 shared paper, 2021 · strength 0.17
- Paper LINC00261 elevation inhibits angiogenesis and cell cycle progression of pancreatic cancer cells by upregulating SCP2 vi… DOI 10.1111/jcmm.16930 ↗
Jun Zou · 1 shared paper, 2021 · strength 0.17
- Paper LINC00261 elevation inhibits angiogenesis and cell cycle progression of pancreatic cancer cells by upregulating SCP2 vi… DOI 10.1111/jcmm.16930 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.